This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Cheryl T Motley: Innovator in HTLV-II Detection
Introduction
Cheryl T Motley is a notable inventor based in Waukegan, IL (US). She has made significant contributions to the field of virology, particularly in the detection of human T-cell lymphotropic virus type II (HTLV-II). Her work has implications for both medical research and clinical diagnostics.
Latest Patents
Cheryl T Motley holds a patent titled "Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides." This invention relates to a novel HTLV-II isolate designated NRA, which was originally isolated from a patient with atypical hairy cell leukemia. The patent details methods and kits for detecting HTLV-II antibodies using specific envelope proteins encoded by the env gene.
Career Highlights
Motley's career is marked by her innovative research and dedication to advancing medical science. She has been associated with Abbott Laboratories Corporation, where she has contributed to various projects aimed at improving diagnostic methods for viral infections.
Collaborations
Cheryl has worked alongside esteemed colleagues such as Helen H Lee and Priscilla Swanson, contributing to a collaborative environment that fosters innovation and scientific discovery.
Conclusion
Cheryl T Motley exemplifies the spirit of innovation in the field of virology. Her patent on HTLV-II detection methods showcases her commitment to advancing healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile